SUVEN · Suven Life Sciences Limited · Financials
Volume · Nov 13
13.56K
Avg daily vol (14 sessions)
29.11K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
71.15M
+6.9%
FY2026
Net Income
-2.76B
-71.9%
FY2026
Operating Cash Flow
-3.02B
-95.8%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|
| INR | 90.93M | 71.15M | 66.56M | 116.93M | 135.39M | 118.44M | 134.78M | 144.15M | 6.25B |
| INR | 73.86M | 56.14M | 58.22M | 65.02M | 65.43M | 43.93M | 43.46M | 41.69M | 213.1M |
| INR | 10.92M | 1.58M | 466K | 1.58M | 2.89M | 5.3M | 8.15M | 5.51M | 46.28M |
| INR | -3.82B | -2.76B | -1.61B | -1.06B | -1.18B | -1.22B | -774.74M | -1.06B | 1.96B |
| INR | 0 | 0 | 0 | -10.02M | 0 | 0 | -53.23M | -121.83M | 718.38M |
| INR | -3.82B | -2.76B | -1.61B | -1.05B | 0 | 0 | 0 | -942.18M | 1.24B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.